You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

356 Results
Drug
Other Name(s): Lanvis®
Jun 2019
Drug
Other Name(s): Hycamtin®
Apr 2023
Drug
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Drug
Other Name(s): Torisel ®
Jun 2024
Drug
Other Name(s): Yervoy®
Aug 2024
Drug
Other Name(s): Mekinist®
Sep 2021
Drug
Other Name(s): Imbruvica®
Feb 2023
Drug
Other Name(s): Zydelig™
Feb 2022
Drug
Other Name(s): Ninlaro™
Jun 2019
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Funding:
New Drug Funding Program
    Temsirolimus - Metastatic Renal Cell Carcinoma
Jun 2024
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    temozolomide
Jun 2021
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024

Pages